Emerging biomarkers for acute heart conditions

Vlad C. Vasile, Allan S Jaffe

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Galectin-3 is an active biomarker found in inflammatory and fibrotic processes, and is a marker of mortality. ST2 is released by stressed cardiac myocytes and also predicts mortality in heart failure and myocardial infarction. Copeptin is a stable arginine vasopressin precursor associated with increased risk of heart failure. It may also be useful to exclude acute myocardial infarction.

Original languageEnglish (US)
Pages (from-to)312-318
Number of pages7
JournalCurrent Opinion in Cardiology
Volume29
Issue number4
DOIs
StatePublished - 2014

Fingerprint

Heart Failure
Biomarkers
Myocardial Infarction
Galectin 3
Mortality
Arginine Vasopressin
Cardiac Myocytes
copeptins

Keywords

  • Acute coronary syndromes
  • Copeptin
  • Galectin-3
  • Heart failure
  • ST2

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Emerging biomarkers for acute heart conditions. / Vasile, Vlad C.; Jaffe, Allan S.

In: Current Opinion in Cardiology, Vol. 29, No. 4, 2014, p. 312-318.

Research output: Contribution to journalArticle

Vasile, Vlad C. ; Jaffe, Allan S. / Emerging biomarkers for acute heart conditions. In: Current Opinion in Cardiology. 2014 ; Vol. 29, No. 4. pp. 312-318.
@article{d68d0d1b93724a129ca065c5074f61b5,
title = "Emerging biomarkers for acute heart conditions",
abstract = "Galectin-3 is an active biomarker found in inflammatory and fibrotic processes, and is a marker of mortality. ST2 is released by stressed cardiac myocytes and also predicts mortality in heart failure and myocardial infarction. Copeptin is a stable arginine vasopressin precursor associated with increased risk of heart failure. It may also be useful to exclude acute myocardial infarction.",
keywords = "Acute coronary syndromes, Copeptin, Galectin-3, Heart failure, ST2",
author = "Vasile, {Vlad C.} and Jaffe, {Allan S}",
year = "2014",
doi = "10.1097/HCO.0000000000000077",
language = "English (US)",
volume = "29",
pages = "312--318",
journal = "Current Opinion in Cardiology",
issn = "0268-4705",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Emerging biomarkers for acute heart conditions

AU - Vasile, Vlad C.

AU - Jaffe, Allan S

PY - 2014

Y1 - 2014

N2 - Galectin-3 is an active biomarker found in inflammatory and fibrotic processes, and is a marker of mortality. ST2 is released by stressed cardiac myocytes and also predicts mortality in heart failure and myocardial infarction. Copeptin is a stable arginine vasopressin precursor associated with increased risk of heart failure. It may also be useful to exclude acute myocardial infarction.

AB - Galectin-3 is an active biomarker found in inflammatory and fibrotic processes, and is a marker of mortality. ST2 is released by stressed cardiac myocytes and also predicts mortality in heart failure and myocardial infarction. Copeptin is a stable arginine vasopressin precursor associated with increased risk of heart failure. It may also be useful to exclude acute myocardial infarction.

KW - Acute coronary syndromes

KW - Copeptin

KW - Galectin-3

KW - Heart failure

KW - ST2

UR - http://www.scopus.com/inward/record.url?scp=84904814397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904814397&partnerID=8YFLogxK

U2 - 10.1097/HCO.0000000000000077

DO - 10.1097/HCO.0000000000000077

M3 - Article

C2 - 24806784

AN - SCOPUS:84904814397

VL - 29

SP - 312

EP - 318

JO - Current Opinion in Cardiology

JF - Current Opinion in Cardiology

SN - 0268-4705

IS - 4

ER -